Found: 7
Select item for more details and to access through your institution.
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics.
- Published in:
- BMC Bioinformatics, 2016, v. 17, p. 1, doi. 10.1186/s12859-016-1062-1
- By:
- Publication type:
- Article
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 118, doi. 10.1111/bjh.12486
- By:
- Publication type:
- Article
Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2669, doi. 10.3390/cancers12092669
- By:
- Publication type:
- Article
Epigenetics in Myeloproliferative Neoplasms.
- Published in:
- Journal of Cellular & Molecular Medicine, 2017, v. 21, n. 9, p. 1660, doi. 10.1111/jcmm.13095
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.
- Published in:
- Case Reports in Hematology, 2012, p. 1, doi. 10.1155/2012/458716
- By:
- Publication type:
- Article
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- journal article